Lv51
1530 积分 2022-10-10 加入
Significant increase in MIC-A and MIC-B and soluble MIC-A and MIC-B in canine lymphomas
1小时前
求助中
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program
5天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
7天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
7天前
已完结
Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
11天前
已完结
Biology and regulation of IL-2: from molecular mechanisms to human therapy
13天前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
13天前
已完结
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer
19天前
已完结
Trop2, Nectin-4, and PD-L1 expression profiles in esophageal squamous cell carcinoma: Implications for combined immunotherapy and ADC targeted therapies
22天前
已完结
Associations of TACSTD2/TROP2 and NECTIN‐4/NECTIN‐4 with molecular subtypes, PD‐L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts
22天前
已完结
皖公网安备34019202002308
